139 filings
Page 5 of 7
8-K
0lijlmvcmn7mhak00o73
11 Apr 13
Departure of Directors or Certain Officers
12:00am
424B4
23eqll
8 Mar 13
Prospectus supplement with pricing info
12:00am
EFFECT
ynsk1smu6nspi
7 Mar 13
Notice of effectiveness
12:00am
S-1MEF
0bzoj t36
7 Mar 13
Registration of additional securities for an S-1
12:00am
CORRESP
ahk906mj8ycfsb
5 Mar 13
Correspondence with SEC
12:00am
CORRESP
yi1fx
5 Mar 13
Correspondence with SEC
12:00am
CT ORDER
krrhve pjx82om
4 Mar 13
Confidential treatment order
12:00am
UPLOAD
qczw1 mwzwp066
4 Mar 13
Letter from SEC
12:00am
10-K/A
fd3 gj0k18f
26 Feb 13
Annual report (amended)
12:00am
10-K
oqr94hop
25 Feb 13
Annual report
12:00am
8-K
hbu7ds ijk
25 Feb 13
Hyperion Therapeutics Announces Fourth Quarter and Full Year 2012
12:00am
8-K
832jn5
25 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
qi8sbajh
20 Feb 13
Entry into a Material Definitive Agreement
12:00am
8-K
94r60
1 Feb 13
Other Events
12:00am
8-K
9p6sd
22 Jan 13
Other Events
12:00am
8-K
jr8ch jzf
16 Jan 13
Other Events
12:00am
8-K
opzmkhsx59vm
4 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
ha75lkjepv
8 Nov 12
Hyperion Therapeutics Announces Third Quarter 2012 Operating Results
12:00am